Characteristics associated with the presence and development of extra-articular manifestations in ankylosing spondylitis: 12-year results from OASIS
Authors:
- Ivette EssersIEIvette Essers
- Sofia RamiroSRSofia Ramiro
- Carmen StolwijkCSCarmen Stolwijk
- Marc BlaauwMBMarc Blaauw
- Robert LandewéRLRobert Landewé
- Désirée van der HeijdeDHDésirée van der Heijde
- Filip Van Den BoschFBFilip Van Den Bosch
- Maxime DougadosMDMaxime Dougados
- Astrid van TubergenATAstrid van Tubergen
Open Access
- 17 September 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 54 (4) , 633-640
Abstract
Objective. The aim of this study was to identify characteristics associated with the presence and development of extra-articular manifestations (EAMs) in a prevalence cohort of patients with AS. Methods. Twelve-year follow-up data from the Outcome in Ankylosing Spondylitis International Study (OASIS) were used. In addition, medical charts were checked for the presence of acute anterior uveitis (AAU), IBD and psoriasis. Demographic, clinical and radiographic characteristics associated with the presence of (any) EAM at baseline or new development during follow-up were identified. Results. Two hundred and sixteen patients were included [mean age 43.6 years (s.d. 12.7), 154 (71%) men, mean symptom duration 20.5 years (s.d. 11.7), mean follow-up 8.3 years (s.d. 4.3)]. At baseline, 39 (18%) patients had AAU, 15 (7%) had IBD and 9 (4%) had psoriasis. The history of AAU was univariably associated with increased age [odds ratio (OR) 1.04 (95% CI 1.01, 1.07)], longer symptom duration [OR 1.05 (95% CI 1.02, 1.08)] and more radiographic damage [OR 1.02 (95% CI 1.00, 1.04)]. The history of psoriasis was associated with greater age [OR 1.05 (95% CI 1.00, 1.11)] and lower CRP [OR 0.77 (95% CI 0.59, 1.00)]. At follow-up, 27 patients developed a new EAM. Newly developed IBD was associated with a higher time-varying AS Disease Activity Score [hazard ratio (HR) 2.80 (95% CI 1.43, 5.52)], worse physical function [HR 1.40 (95% CI 1.09, 1.80)] and worse patient global well-being [HR 1.46 (95% CI 1.10, 1.93)]. Newly developed AAU was associated with an elevated time-varying CRP [HR 1.02 (95% CI 1.01, 1.04)]. Conclusion. Development of EAMs was infrequent in this cohort, despite relatively long follow-up. In particular, markers of disease activity were associated with the development of IBD.Keywords
This publication has 24 references indexed in Scilit:
- Ankylosing spondylitis patients with and without psoriasis do not differ in disease phenotypeAnnals of the Rheumatic Diseases, 2013
- Psoriasis and phenotype of patients with early inflammatory back painAnnals of the Rheumatic Diseases, 2013
- Microscopic gut inflammation in axial spondyloarthritis: a multiparametric predictive modelAnnals of the Rheumatic Diseases, 2013
- Comorbidities in Patients with SpondyloarthritisRheumatic Disease Clinics of North America, 2012
- SpondyloarthritidesBest Practice & Research Clinical Rheumatology, 2011
- Extra-articular manifestations of ankylosing spondylitis: Prevalence, characteristics and therapeutic implicationsEuropean Journal of Internal Medicine, 2011
- Prognosis and follow-up of psoriatic arthritis with peripheral joint involvement: Development of recommendations for clinical practice based on published evidence and expert opinionJoint Bone Spine, 2009
- Treatment of ankylosing spondylitis and extra-articular manifestations in everyday rheumatology practiceRheumatology, 2009
- Prevalence and characteristics of uveitis in the spondyloarthropathies: a systematic literature reviewAnnals of the Rheumatic Diseases, 2008
- Ankylosing spondylitis and bowel diseaseBest Practice & Research Clinical Rheumatology, 2006